Braintree (marketing rights of BLI-800) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Braintree (marketing rights of BLI-800) General Information

Description

Portfolio of rights to a colonic-cleansing product. The portfolio consists of manufacturing, marketing and distribution rights of Braintree's proprietary formulation BLI-800 for colonic cleansing before diagnostic procedures for colorectal cancer screening.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Business Products and Services
Acquirer
Primary Office
  • Paris
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Braintree (marketing rights of BLI-800) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Braintree (marketing rights of BLI-800)‘s full profile, request access.

Request a free trial

Braintree (marketing rights of BLI-800) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Braintree (marketing rights of BLI-800)‘s full profile, request access.

Request a free trial